Fisetin: A Tracking Guide for a Flavonoid Senolytic

Fisetin is a flavonoid found in strawberries, apples, and other plants. In longevity circles it is discussed as a senolytic - a compound that selectively clears senescent cells, the worn-out cells that stop dividing but linger and secrete inflammatory signals. Because senescent-cell clearance is thought to be a periodic rather than continuous job, fisetin is usually discussed in hit-and-run dosing protocols: high intake for a couple of days, then a long break of weeks or months.

This is an educational tracking guide, not a recommendation. The senolytic idea is exciting in mice; the human evidence is still preliminary.

What it is

• A dietary flavonoid with antioxidant and anti-inflammatory activity
• Studied as a senolytic that may clear senescent cells
• Sold as an ordinary supplement, often in a fat-soluble or liposomal form for absorption

What it does

• May selectively push senescent cells toward death
• Reduces markers of senescence-associated inflammation in animal models
• Has broad antioxidant effects at the doses studied

The senolytic context

• The most studied senolytic combination in humans is dasatinib plus quercetin (D+Q), a chemotherapy drug paired with a flavonoid, used in small clinical trials
• Fisetin is the flavonoid many people reach for instead because it is a food compound rather than a prescription drug
• Human senolytic trials so far are small and early; robust outcome data does not yet exist for fisetin specifically

Typical protocol shape

The commonly described pattern is intermittent high-dose intake over two to three consecutive days, repeated only occasionally (for example every few months), on the theory that clearance is periodic. This is a described protocol from the longevity community, not a dose recommendation, and the right human protocol is unknown.

What to track

• Joint stiffness, aches, and general inflammation before and after a cycle
• Energy and recovery in the weeks following a dosing block
• Digestive tolerance during the high-intake days

Realistic expectations

There is no home biomarker that confirms senescent cells were cleared. The human evidence is mostly preclinical, so the honest expectation is an experimental intervention with a plausible mechanism and no proven human anti-aging outcome. Skepticism is warranted.

Common mistakes

• Treating mouse senolytic results as human proof
• Taking high doses continuously instead of intermittently, defeating the rationale and adding load
• Assuming a food flavonoid at pharmacologic doses is automatically free of interactions

Safety notes

Fisetin is a food-derived flavonoid and is generally well tolerated at dietary levels, but the intermittent high doses used in senolytic protocols are far above what food provides, and long-term safety at those doses is not established. Flavonoids at high doses can interact with medications and affect clotting and drug metabolism. The human senolytic evidence is early, so this remains experimental, and anyone on medication or with a medical condition should consult a clinician first.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.